Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I)
A series of degrasyn-like symmetrical compounds have been designed, synthesized, and screened against B cell malignancy (multiple myeloma, mantle cell lymphoma) cell lines. The lead compounds T5165804 and CP2005 showed higher nanomolar potency against the
Peng, Zhenghong,Maxwell, David S.,Sun, Duoli,Bhanu Prasad, Basvoju A.,Schuber Jr., Paul T.,Pal, Ashutosh,Ying, Yunming,Han, Dongmei,Gao, Liwei,Wang, Shimei,Levitzki, Alexander,Kapuria, Vaibhav,Talpaz, Moshe,Young, Matthew,Showalter, Hollis D.,Donato, Nicholas J.,Bornmann, William G.
p. 1450 - 1458
(2014/03/21)
More Articles about upstream products of 1567834-38-1